Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

25.77
-1.2200-4.52%
Post-market: 25.00-0.7700-2.99%19:36 EDT
Volume:831.91K
Turnover:21.15M
Market Cap:1.52B
PE:-20.08
High:26.25
Open:26.22
Low:24.30
Close:26.99
Loading ...
Oct 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities